European Medicines Agency confirms eligibility for submission of Moderna’s COVID-19 vaccine candidate mRNA-1273

Confirmation was received in response to submission of letter of intent, enabling Moderna to evaluate opportunity for submitting marketing authorisation application for mRNA-1273 following positive results from preclinical viral challenge study & interim analysis of phase I study

Source:

PharmaTimes